Osteoporosis in rheumatoid arthritis and ankylosing spondylitis

Clinical and Experimental Rheumatology

Volumn 27, Issue 4 SUPPL. 55, 2009, Pages

  Vosse, Debby ^a   De Vlam, Kurt ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Ankylosing spondylitis; Bone fragility; Osteoporosis; Rheumatoid arthritis

Indexed keywords

CORTICOSTEROID;

ANKYLOSING SPONDYLITIS; BONE DENSITY; BONE EROSION; BONE FRAGILITY; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG USE; EXERCISE; GROUPS BY AGE; HUMAN; INFLAMMATION; KYPHOSIS; MORPHOMETRICS; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PATHOPHYSIOLOGY; PERIARTICULAR JOINT DISEASE; PHENOTYPE; PHYSICAL DISEASE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; VERTEBRA FRACTURE;

ARTHRITIS, RHEUMATOID; BONE AND BONES; BONE DENSITY; BONE REMODELING; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; FRACTURES, BONE; HUMANS; MALE; OSTEOGENESIS; OSTEOPOROSIS; PREVALENCE; SPONDYLITIS, ANKYLOSING;

EID: 71249094702     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. WALSH NC, CROTTI TN, GOLDRING SR, GRAVALLESE EM: Rheumatic diseases: the effects of inflammation on bone. Immunol Rev 2005; 208: 228-251 (Pubitemid 41746396)
2. PETTIT AR, WALSH NC, MANNING C, GOLDRING SR, GRAVALLESE EM: RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis. Rheumatology (Oxford). 2006; 45: 1068-1076
3. DIARRA D, STOLINA M, POLZER K et al.: Dickkopf-1 is a master regulator of joint remodeling. Nat Med 2007; 13: 156-163
4. SINIGAGLIA L, VARENNA M, GIRASOLE G, BIANCHI G: Epidemiology of osteoporosis in rheumatic diseases. Rheum Dis Clin North Am 2006; 32: 631-658
5. HARRISON BJ, HUTCHINSON CE, ADAMS J, BRUCE IN, HERRICK AL: Assessing periarticular bone mineral density in patients with early psoriatic arthritis or rheumatoid arthritis. Ann Rheum Dis 2002; 61: 1007-1011 (Pubitemid 35221691)
6. VAN DER HEIJDE DMFM: Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol 1995; 34 (Suppl. 2): 74-78 (Pubitemid 26013493)
7. MCQUEEN FM, STEWART N, CRABBE J et al.: Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset. Ann Rheum Dis 1998; 57: 350-356
8. MCGONAGLE D, CONAGHAN PG, O'CONNOR P et al.: The relationship between synovitis and bone changes in early untreated rheumatoid arthritis: a controlled magnetic resonance imaging study. Arthritis Rheum 1999; 42: 1706-1711
9. BOYLE WJ, SIMONET WS, LACEY DL: Osteoclast differentiation and activation. Nature 2003; 423: 337-342
10. SIEPER J, APPEL H, BRAUN J, RUDWALEIT M: Critical appraisal of assessment of structural damage in ankylosing spondylitis: implications for treatment outcomes. Arthritis Rheum 2008; 58: 649-656
11. LORIES RJ, LUYTEN FP, DE VLAM K: Progress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis. Arthritis Res Ther 2009; 11: 221.
12. TENGSTRAND B, HAFSTRÖM I: Bone mineral density in men with rheumatoid arthritis is associated with erosive disease and sulfasalazine treatment but not with sex hormones. J Rheumatol 2002; 29: 2299-2305
13. HAUGEBERG G, UHLIG T, FALCH JA, HALSE JI, KVIEN TK: Reduced bone mineral density in male rheumatoid arthritis patients: frequencies and associations with demographic and disease variables in ninety-four patients in the Oslo County Rheumatoid Arthritis Register. Arthritis Rheum 2000; 43: 2776-84.
14. VAN STAA TP, GEUSENS P, BIJLSMA JW, LEUFKENS HG, COOPER C: Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 2006; 54: 3104-3111
15. PEEL NF, MOORE DJ, BARRINGTON NA, BAX DE, EASTELL R: Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 1995; 54: 801-806
16. ØRSTAVIK RE, HAUGEBERG G, MOWINCKEL P et al.: Vertebral deformities in rheumatoid arthritis: a comparison with population-based controls. Arch Intern Med 2004; 164: 420-425
17. HUUSKO TM, KORPELA M, KARPPI P, AVIKAINEN V, KAUTIAINEN H, SULKAVA R: Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland. Ann Rheum Dis 2001; 60: 521-522
18. COULSON KA, REED G, GILLIAM BE, KREMER JM, PEPMUELLER PH: Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the consortium of rheumatology researchers of North American Registry. J Clin Rheumatol 2009 (in press).
19. COHEN SB, DORE RK, LANE NE et al.: Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. Arthritis Rheum 2008; 58: 1299-1309
20. VIS M, HAVAARDSHOLM EA, HAUGEBERG G et al.: Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis. Ann Rheum Dis 2006; 65: 1495-1499
21. MAWATARI T, MIURA H, HAMAI S et al.: Vertebral strength changes in rheumatoid arthritis patients treated with alendronate, as assessed by finite element analysis of clinical computed tomography scans: a prospective randomized clinical trial. Arthritis Rheum 2008; 58: 3340-3349
22. BESSANT R, KEAT A: How should clinicians manage osteoporosis in ankylosing spondylitis? J Rheumatol 2002; 29: 1511-1519
23. GRAN JT, HUSBY G: Clinical, epidemiological, and therapeutic aspects of ankylosing spondylitis. Curr Opin Rheumatol 1998; 10: 292-298
24. DEVOGELAER JP, MALDAGUE B, MALGHEM J, NAGANT DE DEUXCHAISNES C: Appendicular and vertebral bone mass in ankylosing spondylitis. A comparison of plain radiographs with single- and dual-photon absorptiometry and with quantitative computed tomography. Arthritis Rheum 1992; 35: 1062-1067
25. WILL R, PALMER R, BHALLA AK, RING EFJ, CALIN A: Osteoporosis in early ankylosing spondylitis: a primary pathologic event? Lancet 1989; 2: 1483-1485
26. COOPER C, CARBONE L, MICHET CJ, ATKINSON EJ, O'FALLON WM, MELTON LJ 3RD: Fracture risk in patients with ankylosing spondylitis: a population based study. J Rheumatol 1994; 21: 1877-1882
27. LEE YS, SCHLOTZHAUER T, OTT SM et al.: Skeletal status of men with early and late ankylosing spondylitis. Am J Med 1997; 103: 233-241
28. DONNELLY S, DOYLE DV, DENTON A, ROLFE I, MCCLOSKEY EV, SPECTOR TD: Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis 1994; 53: 117-121
29. BRONSON WD, WALKER SE, HILLMAN LS, KEISLER D, HOYT T, ALLEN SH: Bone mineral density and biochemical markers of bone metabolism in ankylosing spondylitis. J Rheumatol 1998; 25: 929-935
30. CHAVASSIEUX P, SEEMAN E, DELMAS PD: Insights into material and structural basis of bone fragility from diseases associated with fractures. How determinants of the biomechanical properties of bone are compromised by disease. Endocr Rev 2007; 28: 151-164
31. DEODHAR AA, WOOLF AD: Bone mass measurement and bone metabolism in rheumatoid arthritis: a review. Br J Rheumatol 1996; 35: 309-322
32. GRATACOS J, COLLADO A, PONS F et al.: Significant loss of bone mass in patients with early, active ankylosing spondylitis: a follow up study. Arthritis Rheum 1999; 42: 2319-24.
33. MITRA D, ELVINS DM, SPEDEN DJ, COLLINS AJ: The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density. Rheumatology 2000; 39: 85-89
34. HUNTER T, DUBO HIC: Spinal fractures complicating ankylosing spondylitis. A long-term follow-up study. Arthritis Rheum 1983; 26: 751-759
35. GENANT HK, WU CY, KUIJK VAN C, NEVITT MC: Vertebral fracture assessment using a semi quantitative technique. J Bone Miner Res 1993; 8: 1137-1148
36. NGUYEN HV, LUDWIG S, GELB D: Osteoporotic vertebral burst fractures with neurologic compromise. J Spin Dis Techn 2003; 16: 10-19
37. VOSSE D, FELDTKELLER E, ERLENDSSON J, GEUSENS P, VAN DER LINDEN S: Clinical vertebral fractures in patients with Ankylosing Spondylitis. J Rheumatol 2004; 31: 1981-1985
38. RALSTON SH, URQUHART GDK, BRZESKI M, STURROCK RD: Prevalence of vertebral com- pression fractures due to osteoporosis in ankylosing spondylitis. BMJ 1990; 300: 563-565
39. VOSSE D, LANDEWÉ R, VAN DER HEIJDE D, VAN DER LINDEN S, VAN STAA TP, GEUSENS P: Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case control study. Ann Rheum Dis 2008 Dec 9. [Epub ahead of print].
40. REID DM, NICOLL JJ, KENNEDY NJS et al.: Bone mass in ankylosing spondylitis. J Rheumatol 1986; 13: 932-935
41. GEUSENS P, VOSSE D, VAN DER HEIJDE D et al.: High prevalence of thoracic vertebral deformities and discal wedging in ankylosing spondylitis patients with hyperkyphosis. J Rheumatol 2001; 28: 1856-1861
42. CARETTE S, GRAHAM D, LITTLE H, RUBENSTEIN J, ROSEN P: The natural disease course of ankylosing spondylitis. Arthritis Rheum 1983; 26: 186-190
43. WILKINSON M, BYWATERS EGL: Clinical features and course of ankylosing spondylitis. Ann Rheum Dis 1958; 17: 209-216
44. SPENCER DG, PARK WM, DICK HM, PAPAZOGLOU SN, BUCHANAN WW: Radiological manifestations in 200 patients with ankylosing spondylitis: correlation with clinical features and HLA-B27. J Rheumatol 1979; 6: 305-315
45. MCMASTER MJ: Osteotomy of the cervical spine in ankylosing spondylitis. J Bone Joint Surg (Br) 1997; 79: 197-203.
46. SPOORENBERG A, VAN DER HEIJDE D, DE KLERK E et al.: A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis. J Rheumatol 1999; 26: 961-965
47. HUNTER T, DUBO HIC: Spinal fractures complicating ankylosing spondylitis. A long-term follow-up study. Arthritis Rheum 1983; 26: 751-759
48. VOSSE D, VAN DER HEIJDE DM, LANDEWÉ R et al.: Determinants of hyperkyphosis in patients with Ankylosing Spondylitis. Ann Rheum Dis 2006; 65: 770-774 (Pubitemid 43803770)
49. GARNERO P, LANDEWÉ R, MAARTEN B et al.: Association of baseline levels of markers of bone and cartilage degradation are associated with long-term progression of joint damage in patients with early rheumatoid arthritis: the Cobra study. Arthritis Rheum 2002; 46: 2847-2856
50. LANDEWÉ RB, GEUSENS P, VAN DER HEIJDE DM, BOERS M, VAN DER LINDEN SJ, GARNERO P: Arthritis instantaneously causes collagen type I and type II degradation in patients with early rheumatoid arthritis: a longitudinal analysis. Ann Rheum Dis 2006; 65: 40-44
51. RITCHLIN CT, HAAS-SMITH SA, LI P, HICKS DG, SCHWARZ EM: Mechanisms of TNF-α and RANKL mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest 2003; 111: 821-831
52. GARNERO P, GINEYTS E, CHRISTGAU S, FINCK B, DELMAS PD: Association of baseline levels of urinary glucosyl-galactosylpyridinoline and type II collagen C-Telopeptide are associated with progression of joint destruction in patients with early rheumatoid arthritis. Arthritis Rheum 2002; 46: 21-30.
53. GARNERO P, LANDEWÉ R, MAARTEN B et al.: Association of baseline levels of markers of bone and cartilage degradation are associated with long-term progression of joint damage in patients with early rheumatoid arthritis: the Cobra study. Arthritis Rheum 2002; 46: 2847-2856
54. LANDEWÉ RB, GEUSENS P, VAN DER HEIJDE DM, BOERS M, VAN DER LINDEN SJ, GARNERO P: Arthritis instantaneously causes collagen type I and type II degradation in patients with early rheumatoid arthritis: a longitudinal analysis. Ann Rheum Dis 2006; 65: 40-44
55. GARNERO P, DELMAS PD: Noninvasive techniques for assesing skeletal changes in inflammatory arthritis: bone biomarkers. Curr Opin Rheumatol 2004; 16: 428-434
56. TOUSSIROT E, RICARD-BLUM S, DUMOULIN G, CEDOZ JP, WENDLING D: Relationship between urinary pyridinium cross-links, disease activity and disease subsets of ankylosing spondylitis. Rheumatology 1999; 38: 21-37.
57. KIM TH, STONE M, PAYNE U et al.: Cartilage biomarkers in ankylosing spondylitis relationship to clinical variables and treatment response. Arthritis Rheum 2005; 52: 885-891
58. MAKSYMOWYCH WP, POOLE AR, HIEBERT L et al.: Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis. J Rheumatol 2005; 32: 1911-1917
59. VOSSE D, LANDEWÉ R, GARNERO P, VAN DER HEIJDE D, VAN DER LINDEN S, GEUSENS P: Association of markers of bone- and cartilage degradation with radiological changes at baseline and after 2 years follow-up in patients with ankylosing spondylitis. Rheumatol 2008; 47: 1219-1222